Episode 022: Spending for Launch Success
Categorías:
When it comes to investing in the launch of your biopharma product, how much is too much? Is there such a thing as too little? Director Sachin Purwar and his colleagues from the Commercial Strategy & Planning practice of Syneos Health Consulting set out to answer these questions - and found the "sweet spot" for launch spending that could mean the difference between success and failure. The team's review of 19 emerging biopharma company launches was recently published in IN VIVO. In ...
